Viper Cathéter de thrombolyse ULTRA

Viper Cathéter de thrombolyse ULTRA

Un ultra cathéter de perfusion spécialisé pour direct l'administration de thrombolytiques, avec multi-trous de distribuer uniformément les médicaments dans de vastes segments de coagulation.

Informations

Le Viper® Ultrasonic Pharmacomechanical Thrombolysis System est un peu invasif dispositif conçu pour dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin et increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications et preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

Spécifications des produits

Spécifications Détail / Valeur
Nom du produit Viper Cathéter de thrombolyse ULTRA
Utilisation prévue Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Conception du cathéter Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Matériau Pebax/Polyamide shaft, potentially braided or reinforced
Diamètre extérieur (F) ~4–6F (depending on infusion lumen capacity)
Longueur de travail ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Compatibilité des fils-guides Typically 0.014” or 0.018”
Stérilité Stérile, à usage unique
Durée de conservation ~2-3 ans si conservé à 15-25 °C dans un emballage scellé
Indications cliniques Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Contre-indications Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Commande et matrice des tailles

Diamètre extérieur (F) Longueur de travail (cm) Infusion Segment (cm) Code produit Notes
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment

Produits similaires